1
|
Chen C, Yuan P, Zhang Z. Nanomedicine-based cancer immunotherapy: a bibliometric analysis of research progress and prospects. Front Immunol 2024; 15:1446532. [PMID: 39247199 PMCID: PMC11377264 DOI: 10.3389/fimmu.2024.1446532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2024] [Accepted: 08/05/2024] [Indexed: 09/10/2024] Open
Abstract
Despite the increasing number of studies on nanomedicine-based cancer immunotherapy, the overall research trends in this field remain inadequately characterized. This study aims to evaluate the research trends and hotspots in nanomedicine-based cancer immunotherapy through a bibliometric analysis. As of March 31, 2024, relevant publications were retrieved from the Web of Science Core Collection. Analytical tools including VOSviewer, CiteSpace, and an online bibliometric analysis platform were employed. A total of 5,180 publications were analyzed. The study reveals geographical disparities in research output, with China and the United States being the leading contributors. Institutionally, the Chinese Academy of Sciences, University of Chinese Academy of Sciences, and Sichuan University are prominent contributors. Authorship analysis identifies key researchers, with Liu Zhuang being the most prolific author. "ACS Nano" and the "Journal of Controlled Release and Biomaterials" are identified as the leading journals in the field. Frequently occurring keywords include "cancer immunotherapy" and "drug delivery." Emerging frontiers in the field, such as "mRNA vaccine," "sonodynamic therapy," "oral squamous cell carcinoma," "STING pathway,"and "cGAS-STING pathway," are experiencing rapid growth. This study aims to provide new insights to advance scientific research and clinical applications in nanomedicine-based cancer immunotherapy.
Collapse
Affiliation(s)
- Chaofan Chen
- Department of Anorectal, Kunming Municipal Hospital of Traditional Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, Yunnan, China
| | - Pengfei Yuan
- Department of Anorectal, Kunming Municipal Hospital of Traditional Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, Yunnan, China
| | - Zhiyun Zhang
- Department of Anorectal, Kunming Municipal Hospital of Traditional Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, Yunnan, China
| |
Collapse
|
2
|
Dos Santos Fonseca LM, Machado BAS, Oliveira FO, de Jesus Santos JR, da Silva JW, Hodel KVS, Rosatti BG, Pinto CD, Soares MBP. An overview on recent patents and technologies on nanoparticles for nucleic acid delivery. Expert Opin Ther Pat 2024; 34:171-186. [PMID: 38578253 DOI: 10.1080/13543776.2024.2338097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2023] [Accepted: 03/21/2024] [Indexed: 04/06/2024]
Abstract
INTRODUCTION Nucleic acid-based therapeutics offer groundbreaking potential for treating genetic diseases and advancing next-generation vaccines. Despite their promise, challenges in efficient delivery persist due to the properties of nucleic acids. Nanoparticles (NPs) serve as vital carriers, facilitating effective delivery to target cells, and addressing these challenges. Understanding the global landscape of patents in this field is essential for fostering innovation and guiding decision-making for researchers, the pharmaceutical industry, and regulatory agencies. AREAS COVERED This review provides a comprehensive overview of patent compositions, applications, and manufacturing aspects concerning NPs as nucleic acid delivery systems. It delves into temporal trends, protection locations, market dynamics, and the most influential technological domains. In this work, we provide valuable insights into the advancements and potential of NP-based nucleic acid delivery systems, with a special focus on their pivotal role in advancing cutting-edge therapeutic solutions. EXPERT OPINION Investment in NPs for nucleic acid delivery has significantly surged in recent years. However, translating these therapies into clinical practice faces obstacles, including the need for robust clinical evidence, regulatory compliance, and streamlined manufacturing processes. To address these challenges, our review article summarizes recent advances. We aim to engage researchers worldwide in the development of these promising technologies.
Collapse
Affiliation(s)
- Larissa Moraes Dos Santos Fonseca
- FIOCRUZ Bahia, Gonçalo Moniz Institute (IGM) Oswaldo Cruz Foundation (Fiocruz), Salvador, BA, Brazil
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CIMATEC University Center, Salvador, BA, Brazil
| | - Bruna Aparecida Souza Machado
- FIOCRUZ Bahia, Gonçalo Moniz Institute (IGM) Oswaldo Cruz Foundation (Fiocruz), Salvador, BA, Brazil
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CIMATEC University Center, Salvador, BA, Brazil
| | - Fabricia Oliveira Oliveira
- FIOCRUZ Bahia, Gonçalo Moniz Institute (IGM) Oswaldo Cruz Foundation (Fiocruz), Salvador, BA, Brazil
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CIMATEC University Center, Salvador, BA, Brazil
| | | | - Jaqueline Wang da Silva
- FIOCRUZ Bahia, Gonçalo Moniz Institute (IGM) Oswaldo Cruz Foundation (Fiocruz), Salvador, BA, Brazil
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CIMATEC University Center, Salvador, BA, Brazil
| | - Katharine Valeria Saraiva Hodel
- FIOCRUZ Bahia, Gonçalo Moniz Institute (IGM) Oswaldo Cruz Foundation (Fiocruz), Salvador, BA, Brazil
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CIMATEC University Center, Salvador, BA, Brazil
| | - Brisa Gonçalves Rosatti
- FIOCRUZ Bahia, Gonçalo Moniz Institute (IGM) Oswaldo Cruz Foundation (Fiocruz), Salvador, BA, Brazil
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CIMATEC University Center, Salvador, BA, Brazil
| | | | | |
Collapse
|
3
|
Xuan L, Ju Z, Skonieczna M, Zhou P, Huang R. Nanoparticles-induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models. MedComm (Beijing) 2023; 4:e327. [PMID: 37457660 PMCID: PMC10349198 DOI: 10.1002/mco2.327] [Citation(s) in RCA: 29] [Impact Index Per Article: 29.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Revised: 06/04/2023] [Accepted: 06/09/2023] [Indexed: 07/18/2023] Open
Abstract
Nanoparticles (NPs) have become one of the most popular objects of scientific study during the past decades. However, despite wealth of study reports, still there is a gap, particularly in health toxicology studies, underlying mechanisms, and related evaluation models to deeply understanding the NPs risk effects. In this review, we first present a comprehensive landscape of the applications of NPs on health, especially addressing the role of NPs in medical diagnosis, therapy. Then, the toxicity of NPs on health systems is introduced. We describe in detail the effects of NPs on various systems, including respiratory, nervous, endocrine, immune, and reproductive systems, and the carcinogenicity of NPs. Furthermore, we unravels the underlying mechanisms of NPs including ROS accumulation, mitochondrial damage, inflammatory reaction, apoptosis, DNA damage, cell cycle, and epigenetic regulation. In addition, the classical study models such as cell lines and mice and the emerging models such as 3D organoids used for evaluating the toxicity or scientific study are both introduced. Overall, this review presents a critical summary and evaluation of the state of understanding of NPs, giving readers more better understanding of the NPs toxicology to remedy key gaps in knowledge and techniques.
Collapse
Affiliation(s)
- Lihui Xuan
- Department of Occupational and Environmental HealthXiangya School of Public HealthCentral South UniversityChangshaHunanChina
| | - Zhao Ju
- Department of Occupational and Environmental HealthXiangya School of Public HealthCentral South UniversityChangshaHunanChina
| | - Magdalena Skonieczna
- Department of Systems Biology and EngineeringInstitute of Automatic ControlSilesian University of TechnologyGliwicePoland
- Biotechnology Centre, Silesian University of TechnologyGliwicePoland
| | - Ping‐Kun Zhou
- Beijing Key Laboratory for RadiobiologyDepartment of Radiation BiologyBeijing Institute of Radiation MedicineBeijingChina
| | - Ruixue Huang
- Department of Occupational and Environmental HealthXiangya School of Public HealthCentral South UniversityChangshaHunanChina
| |
Collapse
|
4
|
Rambaran T, Schirhagl R. Nanotechnology from lab to industry - a look at current trends. NANOSCALE ADVANCES 2022; 4:3664-3675. [PMID: 36133326 PMCID: PMC9470025 DOI: 10.1039/d2na00439a] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/06/2022] [Accepted: 07/29/2022] [Indexed: 06/16/2023]
Abstract
Nanotechnology holds great promise and is hyped by many as the next industrial evolution. Medicine, food and cosmetics, agriculture and environmental health, and technology industries already profit from nanotechnology innovations and their influence is expected to increase drastically in the near future. However, there are also many challenges that need to be overcome to bring a nanotechnological product or business to the market. In this article we discuss current examples of nanotechnology that have been successfully introduced in the market and their relevance and geographical spread. We then discuss different partners for scientists and their role in the commercialization process. Finally, we review the different steps it takes to bring a nanotechnology to the market, highlight the many difficulties related to these steps, and provide a roadmap for the journey from lab to industry which can be beneficial to researchers.
Collapse
Affiliation(s)
- Theresa Rambaran
- Department of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University 90187 Umeå Sweden
| | - Romana Schirhagl
- Department of Biomedical Engineering, University Medical Center Groningen, Groningen University Antonius Deusinglaan 1 9713AW Groningen The Netherlands
| |
Collapse
|
5
|
Limocon JRA, Madalag LMC, Reliquias PJB, Tionko JVS, Fermin JL, Kee SL, Tan MJT, Jonco MJLJ, Pomperada MJF. Small but Terrible: Utilizing Chitosan-Based Nanoparticles as Drug Carriers to Treat Tuberculosis in the Philippines. Front Pharmacol 2021; 12:752107. [PMID: 34690783 PMCID: PMC8527166 DOI: 10.3389/fphar.2021.752107] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2021] [Accepted: 09/24/2021] [Indexed: 11/13/2022] Open
Affiliation(s)
| | | | | | | | - Jamie Ledesma Fermin
- Department of Electronics Engineering, University of St. La Salle, Bacolod, Philippines
| | - Shaira Limson Kee
- Department of Natural Sciences, University of St. La Salle, Bacolod, Philippines
| | - Myles Joshua Toledo Tan
- Department of Natural Sciences, University of St. La Salle, Bacolod, Philippines.,Department of Chemical Engineering, University of St. La Salle, Bacolod, Philippines
| | | | | |
Collapse
|
6
|
Dong P, Rakesh K, Manukumar H, Mohammed YHE, Karthik C, Sumathi S, Mallu P, Qin HL. Innovative nano-carriers in anticancer drug delivery-a comprehensive review. Bioorg Chem 2019; 85:325-336. [DOI: 10.1016/j.bioorg.2019.01.019] [Citation(s) in RCA: 67] [Impact Index Per Article: 13.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2018] [Revised: 01/07/2019] [Accepted: 01/08/2019] [Indexed: 02/07/2023]
|
7
|
Yang S, Gao X, He Y, Hu Y, Xu B, Cheng Z, Xiang M, Xie Y. Applying an innovative biodegradable self-assembly nanomicelles to deliver α-mangostin for improving anti-melanoma activity. Cell Death Dis 2019; 10:146. [PMID: 30770785 PMCID: PMC6377678 DOI: 10.1038/s41419-019-1323-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2018] [Revised: 12/20/2018] [Accepted: 01/07/2019] [Indexed: 02/05/2023]
Abstract
α-Mangostin (αM), a traditional natural product with promising application of treating a series of diseases, was limited use in clinical due to its hydrophobicity. Herein, MPEG-PCL nanomicelles were used to embed the αM for resolving hydrophobicity and improving the anti-melanoma effect of the αM. The anti-melanoma activity and potential mechanisms of biodegradable αM/MPEG-PCL nanomicelles were investigated. The αM/MPEG-PCL nanomicelles possessed a stronger effect on anti-melanoma compared to the free αM both in vitro and in vivo with a low cytotoxicity in non-tumor cell lines. In the research of mechanisms, the αM/MPEG-PCL nanomicelles inhibited the proliferation of melanoma cell, induced apoptosis via both apoptosis pathways of intrinsic and exogenous in vitro, as well as suppressed tumor growth and restrained angiogenesis in vivo, which implied that the αM/MPEG-PCL nanomicelles have potential application as a novel chemotherapeutic agent in melanoma therapy.
Collapse
Affiliation(s)
- Shuping Yang
- Department of Neurosurgery and Institute of Neurosurgery, State Key Lab of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China
| | - Xiang Gao
- Department of Neurosurgery and Institute of Neurosurgery, State Key Lab of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China.
| | - Yihong He
- Department of Neurosurgery and Institute of Neurosurgery, State Key Lab of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China
| | - Yuzhu Hu
- Department of Neurosurgery and Institute of Neurosurgery, State Key Lab of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China
| | - Bocheng Xu
- Department of Neurosurgery and Institute of Neurosurgery, State Key Lab of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China
| | - Zhiqiang Cheng
- Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA
| | - Mingli Xiang
- Department of Neurosurgery and Institute of Neurosurgery, State Key Lab of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China.
| | - Yongmei Xie
- Department of Neurosurgery and Institute of Neurosurgery, State Key Lab of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China.
| |
Collapse
|
8
|
Bishoge OK, Zhang L, Suntu SL, Jin H, Zewde AA, Qi Z. Remediation of water and wastewater by using engineered nanomaterials: A review. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH. PART A, TOXIC/HAZARDOUS SUBSTANCES & ENVIRONMENTAL ENGINEERING 2018; 53:537-554. [PMID: 29364029 DOI: 10.1080/10934529.2018.1424991] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Nanotechnology is currently a fast-rising socioeconomic and political knowledge-based technology owing to the unique characteristics of its engineered nanomaterials. This branch of technology is useful for water and wastewater remediation. Many scientists and researchers have been conducting different studies and experiments on the applications of engineered nanomaterials at the local to international level. This review mainly aims to provide a current overview of existing knowledge on engineered nanomaterials and their applications in water and wastewater remediation. Furthermore, the present risks and challenges of nanotechnology are examined.
Collapse
Affiliation(s)
- Obadia K Bishoge
- a Beijing Key Laboratory of Resource-oriented Treatment of Industrial Pollutants , Beijing , PR China
- b School of Energy and Environmental Engineering , University of Science and Technology Beijing , Beijing , PR China
| | - Lingling Zhang
- a Beijing Key Laboratory of Resource-oriented Treatment of Industrial Pollutants , Beijing , PR China
- b School of Energy and Environmental Engineering , University of Science and Technology Beijing , Beijing , PR China
| | - Shaldon L Suntu
- c Information Engineering, School of Computer and Communication Technology , University of Science and Technology Beijing , Beijing , PR China
| | - Hui Jin
- a Beijing Key Laboratory of Resource-oriented Treatment of Industrial Pollutants , Beijing , PR China
- b School of Energy and Environmental Engineering , University of Science and Technology Beijing , Beijing , PR China
| | - Abraham A Zewde
- a Beijing Key Laboratory of Resource-oriented Treatment of Industrial Pollutants , Beijing , PR China
- b School of Energy and Environmental Engineering , University of Science and Technology Beijing , Beijing , PR China
| | - Zhongwei Qi
- a Beijing Key Laboratory of Resource-oriented Treatment of Industrial Pollutants , Beijing , PR China
- b School of Energy and Environmental Engineering , University of Science and Technology Beijing , Beijing , PR China
| |
Collapse
|
9
|
|
10
|
Viswanath B, Kim S. Influence of Nanotoxicity on Human Health and Environment: The Alternative Strategies. REVIEWS OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY 2017; 242:61-104. [PMID: 27718008 DOI: 10.1007/398_2016_12] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Currently, nanotechnology revolutionizing both scientific and industrial community due to their applications in the fields of medicine, environmental protection, energy, and space exploration. Despite of the evident benefits of nanoparticles, there are still open questions about the influence of these nanoparticles on human health and environment. This is one of the critical issues that have to be addressed in the near future, before massive production of nanomaterials. Manufactured nanoparticles, which are finding ever-increasing applications in industry and consumer products fall into the category of emerging contaminants with ecological and toxicological effects on populations, communities and ecosystems. The existing experimental knowledge gave evidence that inhaled nanoparticles are less efficiently separated than larger particles by the macrophage clearance mechanisms and these nanoparticles are known to translocate through the lymphatic, circulatory and nervous systems to many tissues and organs, including the brain. In this review we highlight adverse impacts of nanoparticles on human and the environment with special emphasis on green nanoscience as a sustainable alternative.
Collapse
Affiliation(s)
- Buddolla Viswanath
- Department of Bionanotechnology, Gachon University, San 65, Bokjeong-Dong, Sujeong-Gu, Seongnam-Si, Gyeonggi-Do, 461-701, Republic of Korea
| | - Sanghyo Kim
- Department of Bionanotechnology, Gachon University, San 65, Bokjeong-Dong, Sujeong-Gu, Seongnam-Si, Gyeonggi-Do, 461-701, Republic of Korea.
- Gil Medical Center, Graduate Gachon Medical Research Institute, Incheon, 405-760, Republic of Korea.
| |
Collapse
|
11
|
Bowman DM, Sylvester DJ, Marino AD. Returning to the Patent Landscapes for Nanotechnology: Assessing the Garden that It Has Grown Into. Methods Mol Biol 2017; 1570:315-338. [PMID: 28238147 DOI: 10.1007/978-1-4939-6840-4_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
The patent landscape, like a garden, can tell you much about its designers and users; their motivations, biases, and general interests. While both patent landscapes and gardens may appear to the casual observer as refined and ordered, an in-depth exploration of the terrain is likely to reveal unforeseen challenges including, for example, alien species, thickets, and trolls. As this Chapter illustrates, patent landscapes are dynamic and have been forced to continually evolve in response to technological innovation. While emerging technologies, such as biotechnology and information communication technology have challenged the traditional patent landscape, resulting in the pruning of certain elements here and there, the overarching framework and design has largely remained intact. But will this always be the case? As the field of nanotechnology continues to evolve and mature, the aim of this Chapter is to map how the technology has evolved and grown within the confines of existing structures and underlying foundation of the patent landscape and the implications thereof for the technology, industry, and the public more generally. The Chapter concludes by asking the question whether the current patent landscape will be able to withstand the ubiquitous nature of the technology, or whether nanotechnology, in combination with other emerging technologies, will be a catalyst for governments and policy makers to completely redesign the patent landscape.
Collapse
Affiliation(s)
- Diana M Bowman
- Center for the Study of Law, Science and Technology, Sandra Day O'Connor College of Law, Arizona State University, 877906, Tempe, AZ, 85297, USA.
| | - Douglas J Sylvester
- Center for the Study of Law, Science and Technology, Sandra Day O'Connor College of Law, Arizona State University, 877906, Tempe, AZ, 85297, USA
| | - Anthony D Marino
- Center for the Study of Law, Science and Technology, Sandra Day O'Connor College of Law, Arizona State University, 877906, Tempe, AZ, 85297, USA
| |
Collapse
|